Skip to main content
. 2023 Feb 16;14(2):131. doi: 10.1038/s41419-023-05645-y

Fig. 1. Strategies to augment the cardiac GSH system during myocardial injury.

Fig. 1

Raw materials of GSH or GPX biosynthesis, various small molecule activators related to the GSH system and some novel therapeutic approaches, such as exosomes and gene therapy, enhance the GSH system and thus improve myocardial injury caused by various pathological factors by inhibiting oxidative stress and ferroptosis.